Brief: Integrum Names Rickard Brånemark Chief Medical And Scientific Officer
11/02/2026 14:43
Feb 11 (Reuters) - Integrum AB INTEGb.ST: OPTIMIZES ORGANIZATION TO FURTHER ACCELERATE COMMERCIALIZATION OF OPRA IMPLANT SYSTEM JEFF ZANNI, PRESIDENT US, LEAVES INTEGRUM DR RICKARD BRÅNEMARK APPOINTED CHIEF MEDICAL AND SCIENTIFIC OFFICER ON CONSULTING BASIS Source text: ID:nWkr4Yc27V Further company coverage: [INTEGb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Integrum AB
See all newsBrief: Integrum Announces Publication Of Study On OPRA Implant System
Brief: Integrum Says Ukraine To Launch State-Funded Osseointegration Pilot Program
Sweden's Integrum Q1 sales rise on higher S1 surgeries
Brief: Integrum Q1 EBIT SEK 1.3 Million
Brief: Integrum Gets Additional Custom Duty Refund Of About SEK 3.3 Mln